Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Window of Opportunity for Neoadjuvant Stroma Modification in Pancreatic Cancer

NCT05365893 is registered in ClinicalTrials.gov with Fox Chase Cancer Center as lead sponsor.

NCT NCT05365893
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05365893 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Window of Opportunity for Neoadjuvant Stroma Modification in Pancreatic Cancer
Lead sponsor
Fox Chase Cancer Center
Phase
Phase 1
Overall status
Active, not recruiting
Start date
October 20, 2021
Completion date
December 31, 2026
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic ductal adenocarcinoma